Novartis Institutes for BioMedical Research

Novartis Institutes for BioMedical Research (NIBR) is a research and development company based in Cambridge, Massachusetts. With a workforce of 2,885 employees, NIBR is a significant player in the scientific community. NIBR focuses its research efforts on a broad range of disease areas, including autoimmunity, transplantation, and inflammatory diseases; cardiovascular and metabolic diseases; immuno-oncology; infectious diseases; musculoskeletal diseases; neuroscience; oncology; ophthalmology; and respiratory diseases. Their expertise spans analytical sciences, biologics, biomarker development, chemistry, developmental and molecular pathways, drug metabolism and pharmacokinetics, genomics, imaging, metabolism and pharmacokinetics, preclinical safety, proteomic chemistry, and translational medicine. NIBR leverages advanced technologies such as cellular genomics, proteomics, combinatorial chemistry, and structural biology to drive scientific breakthroughs. NIBR distinguishes itself through its collaborative and innovative culture, fostering an environment where scientists, physicians, and business professionals work together to advance medical practice. The company's commitment to cutting-edge technologies and multidisciplinary approaches enables them to tackle complex diseases from various angles. To connect with NIBR, visit their website at novartis.com/research-development/novartis-institutes-biomedical-research.